Freeport-McMoRan (FCX) Reports Q4 Earnings: What Key Metrics Have to Say

22.01.26 17:00 Uhr

Werte in diesem Artikel
Aktien

50,48 EUR -1,30 EUR -2,51%

Indizes

PKT PKT

3.413,0 PKT 25,5 PKT 0,75%

6.913,4 PKT 37,7 PKT 0,55%

Freeport-McMoRan (FCX) reported $5.63 billion in revenue for the quarter ended December 2025, representing a year-over-year decline of 1.5%. EPS of $0.47 for the same period compares to $0.31 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $5.18 billion, representing a surprise of +8.84%. The company delivered an EPS surprise of +67.98%, with the consensus EPS estimate being $0.28.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Freeport-McMoRan performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Sales in thousands of ounces - Gold - Consolidated basis: 80.00 Koz compared to the 55.09 Koz average estimate based on four analysts.Total Net Cash Cost Per Pound of Copper: $2.22 versus $2.45 estimated by four analysts on average.Sales in thousands of Ounces - Gold - Indonesia: 75.00 Koz compared to the 49.47 Koz average estimate based on three analysts.Sales in thousands of Ounces - Gold - North America: 5.00 Koz versus 5.65 Koz estimated by three analysts on average.Sales in millions of pounds - Copper - Indonesia - Grasberg: 112.00 Mlbs versus 20.43 Mlbs estimated by three analysts on average.Revenues- Indonesia: $960 million versus the three-analyst average estimate of $303.61 million. The reported number represents a year-over-year change of -57.3%.Revenues- Molybdenum: $220 million compared to the $297.1 million average estimate based on three analysts. The reported number represents a change of +24.3% year over year.Revenues- South America copper mines: $1.62 billion versus the three-analyst average estimate of $1.47 billion. The reported number represents a year-over-year change of +34.2%.Revenues- North America copper mines: $2.1 billion compared to the $1.9 billion average estimate based on three analysts. The reported number represents a change of +30.4% year over year.Revenues- Rod & Refining: $1.77 billion compared to the $1.66 billion average estimate based on two analysts. The reported number represents a change of +20.9% year over year.Revenues- Atlantic Copper Smelting & Refining: $820 million compared to the $725.1 million average estimate based on two analysts. The reported number represents a change of +20.8% year over year.Revenues- Corporate, other & eliminations: $-1.86 billion compared to the $-1.39 billion average estimate based on two analysts. The reported number represents a change of +12% year over year.View all Key Company Metrics for Freeport-McMoRan here>>>Shares of Freeport-McMoRan have returned +16.7% over the past month versus the Zacks S&P 500 composite's +0.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Freeport-McMoRan Inc. (FCX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Freeport-McMoRan und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Freeport

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Freeport

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Freeport-McMoRan Inc

Wer­bung

Analysen zu Freeport-McMoRan Inc

DatumRatingAnalyst
16.07.2019Freeport-McMoRan Equal WeightBarclays Capital
11.07.2019Freeport-McMoRan BuyDeutsche Bank AG
11.09.2018Freeport-McMoRan NeutralClarksons Platou
23.05.2018Freeport-McMoRan BuyB. Riley FBR, Inc.
25.04.2018Freeport-McMoRan OutperformCowen and Company, LLC
DatumRatingAnalyst
11.07.2019Freeport-McMoRan BuyDeutsche Bank AG
23.05.2018Freeport-McMoRan BuyB. Riley FBR, Inc.
25.04.2018Freeport-McMoRan OutperformCowen and Company, LLC
06.02.2018Freeport-McMoRan HoldStifel, Nicolaus & Co., Inc.
29.01.2018Freeport-McMoRan OutperformCowen and Company, LLC
DatumRatingAnalyst
16.07.2019Freeport-McMoRan Equal WeightBarclays Capital
11.09.2018Freeport-McMoRan NeutralClarksons Platou
18.01.2018Freeport-McMoRan NeutralB. Riley FBR, Inc.
11.12.2017Freeport-McMoRan NeutralB. Riley FBR, Inc.
01.05.2017Freeport-McMoRan Mkt PerformFBR & Co.
DatumRatingAnalyst
21.02.2017Freeport-McMoRan SellDeutsche Bank AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Freeport-McMoRan Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen